A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses

Vaccine

Volumn 25, Issue 41, 2007, Pages 7065-7074

  Kammer, Andreas R ^a   Amacker, Mario ^a   Rasi, Silvia ^a   Westerfeld, Nicole ^a   Gremion, Christel ^a   Neuhaus, Danielle ^a   Zurbriggen, Rinaldo ^a  

^a Pevion Biotech Ltd   (Switzerland)

Author keywords

Adjuvant; Antibodies; CTLs; Immune response; Influenza; Lyophilisation; Vaccine; Virosomes

Indexed keywords

B LYMPHOCYTE ANTIGEN; CORE 132 ANTIGEN; MALARIA PEPTIDE PHOSPHATIDYLETHANOLAMINE CONJUGATE; OVA 257 264 ANTIGEN; OVALBUMIN; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VIROSOME;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FREEZE DRYING; HUMORAL IMMUNITY; IMMUNOGENICITY; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; CYTOTOXICITY, IMMUNOLOGIC; DRUG STABILITY; DRUG STORAGE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE; VACCINATION; VACCINES, VIROSOME;

EID: 34648837301     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.052     Document Type: Article

References (19)

1. Gluck R., and Metcalfe I.C. Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems. Vaccine 21 7-8 (2003) 611-615
2. Huckriede A., Bungener L., Stegmann T., Daemen T., Medema J., Palache A.M., et al. The virosome concept for influenza vaccines. Vaccine 23 Suppl 1 (2005) S26-S38
3. Moser C., Metcalfe I.C., and Viret J.F. Virosomal adjuvanted antigen delivery systems. Expert Rev Vaccines 2 2 (2003) 189-196
4. Zurbriggen R. Immunostimulating reconstituted influenza virosomes. Vaccine 21 9-10 (2003) 921-924
5. Amacker M., Engler O., Kammer A.R., Vadrucci S., Oberholzer D., Cerny A., et al. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells. Int Immunol 17 6 (2005) 695-704
6. Cusi M.G., Terrosi C., Savellini G.G., Di Genova G., Zurbriggen R., and Correale P. Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine 22 5-6 (2004) 735-739
7. Felnerova D., Viret J.F., Gluck R., and Moser C. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol 15 6 (2004) 518-529
8. Liu X., Siegrist S., Amacker M., Zurbriggen R., Pluschke G., and Seeberger P.H. Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate. ACS Chem Biol 1 3 (2006) 161-164
9. Schumacher R., Amacker M., Neuhaus D., Rosenthal R., Groeper C., Heberer M., et al. Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro. Vaccine 23 48-49 (2005) 5572-5582
10. Westerfeld N., and Zurbriggen R. Peptides delivered by immunostimulating reconstituted influenza virosomes. J Pept Sci 11 11 (2005) 707-712
11. Zurbriggen R., Amacker M., Kammer A.R., Westerfeld N., Borghgraef P., Van Leuven F., et al. Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci 27 2 (2005) 157-166
12. Waelti E.R., and Gluck R. Delivery to cancer cells of antisense l-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes). Int J Cancer 77 5 (1998) 728-733
13. Gluck R. Influenza immunization. Biologicals 25 2 (1997) 221-225
14. Loutan L., Bovier P., Althaus B., and Gluck R. Inactivated virosome hepatitis A vaccine. Lancet 343 8893 (1994) 322-324
15. Moreno R., Jiang L., Moehle K., Zurbriggen R., Gluck R., Robinson J.A., et al. Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design. Chembiochem 2 11 (2001) 838-843
16. Zurbriggen R., Novak-Hofer I., Seelig A., and Gluck R. IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization. Prog Lipid Res 39 1 (2000) 3-18
17. Pascolo S., Bervas N., Ure J.M., Smith A.G., Lemonnier F.A., and Perarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 185 12 (1997) 2043-2051
18. Mueller M.S., Renard A., Boato F., Vogel D., Naegeli M., Zurbriggen R., et al. Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1. Infect Immun 71 8 (2003) 4749-4758
19. Pfeiffer B., Peduzzi E., Moehle K., Zurbriggen R., Gluck R., Pluschke G., et al. A virosome-mimotope approach to synthetic vaccine design and optimization: synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate. Angew Chem Int Ed Engl 42 21 (2003) 2368-2371